Svetlana Atasheva

Showa University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index2.3kcitations44works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(19), Mosquito-borne diseases and control(17), Viral Infections and Vectors(12), Viral Infectious Diseases and Gene Expression in Insects(11), Plant Virus Research Studies(8)

Publications44 total

Contributors
Elsevier eBooks·2025
Innate immune response to adenovirus vectors following intravascular administration
Elsevier eBooks·2025· 1 cited
Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform
Molecular Therapy·2024Open Access
Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform
Molecular Therapy·2023· 17 citedOpen Access
Targeted, Safe, and Efficient Gene Delivery to Human Hematopoietic Stem and Progenitor Cells <i>In Vivo</i> Using Engineered Avid Adenovirus Vector Platform
Blood·2023
p38MAPK guards the integrity of endosomal compartments through regulating necrotic death
Scientific Reports·2022· 3 citedOpen Access
Abstract 2053: Phenotypic and functional analyses of response of lung tumor-associated myeloid cells to systemic oncolytic virotherapy
Cancer Research·2022
Abstract 3366: Novel oncolytic adenovirus for systemic treatment of disseminated lung cancer
Cancer Research·2022
Cytokine Responses to Adenovirus and Adenovirus Vectors
Viruses·2022· 61 citedOpen Access
Oncolytic Viruses for Systemic Administration: Engineering a Whole Different Animal
Molecular Therapy·2021· 18 citedOpen Access
Systemic cancer therapy with engineered adenovirus that evades innate immunity
Science Translational Medicine·2020· 87 citedOpen Access
Abstract 959: Cellular dynamics of productive anti-tumor response mediating long-term rejection of disseminated lung tumors after systemic therapy with oncolytic adenovirus
Cancer Research·2020
Tumor-targeted oncolytic adenovirus demonstrates high cytotoxicity for human lung and renal cell carcinomas independently of the level of tumor PD-L1 expression.
Journal of Clinical Oncology·2020
Innate immunity to adenovirus: lessons from mice
FEBS Letters·2019· 87 citedOpen Access
Abstract 4781: Preclinical assessment of efficacy and safety of novel oncolytic adenovirus for therapy of disseminated lung cancer
Cancer Research·2019· 1 cited
Abstract 4781: Preclinical assessment of efficacy and safety of novel oncolytic adenovirus for therapy of disseminated lung cancer
Experimental and Molecular Therapeutics·2019
Adenovirus sensing by the immune system
Current Opinion in Virology·2016· 60 citedOpen Access
13. Functional Role of Adenovirus Penton in Modulating In Vivo Properties of Liver-Targeted and Liver-Detargeted Adenovirus Variants
Molecular Therapy·2016Open Access
Innate Immune Response to Adenovirus Vector Administration In Vivo
Elsevier eBooks·2016· 6 cited
List of Contributors
Elsevier eBooks·2016
page 1 of 3Next →

Frequent Co-authors

Ilya Frolov(22), Dmitry M. Shayakhmetov(21), Elena I. Frolova(20), Jia Yao(10), Dal‐Young Kim(7), Phoebe L. Stewart(6), Nelson C. Di Paolo(6), Cedrick Young(5), Rodion Gorchakov(4), Natalia Garmashova(4), Maryna Akhrymuk(4), Scott C. Weaver(4), Nicole Wagner(3), Corey C. Emerson(2), Niall J. Foy(2), Ivan Akhrymuk(2), Eryu Wang(2), Henry Wyche(2), Shyambabu Chaurasiya(2), Patrick Hearing(2)